Skip to main content
XRF SCIENTIFIC LIMITED logo

XRF SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · XRF ISIN · AU000000XRF8 ASX Manufacturing
Open in API
Filings indexed 576 across all filing types
Latest filing 2024-09-15 AGM Information
Country AU Australia
Listing ASX XRF

About XRF SCIENTIFIC LIMITED

https://www.xrfscientific.com

XRF Scientific Limited specializes in the design, manufacture, and distribution of equipment and chemicals for sample preparation in scientific analysis. The company provides integrated solutions for X-ray Fluorescence (XRF) and Inductively Coupled Plasma (ICP) applications. Its core product portfolio includes automated fusion machines, high-purity lithium borate fluxes, and precision platinum labware, such as crucibles and molds. These products are utilized to prepare samples for elemental analysis in sectors such as mining, cement, and steel production. XRF Scientific also supplies laboratory equipment and technical support to industrial and research facilities. By managing the production of both specialized machinery and chemical consumables, the company maintains high standards of precision and reliability for complex analytical workflows.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting/Proxy Form 15 pages 903.3KB
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING 2024' and contains detailed information about the upcoming AGM of XRF Scientific Limited, including the date, location, agenda items, resolutions to be voted on, voting procedures, and explanatory statements. It references the annual financial report for the year ended 30 June 2024 but does not contain the financial report itself. The document is a notice and explanatory statement for the AGM, not the actual annual report or financial statements. It includes resolutions such as adoption of the remuneration report, re-election of a director, approval of performance rights, and appointment of auditor, which are typical contents of an AGM notice. The document length is about 15,000 characters, which is consistent with a detailed AGM notice. Therefore, the document fits the category of AGM Information (AGM-R).
2024-09-15 English
Application for quotation of securities - XRF 6 pages 18.5KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used to apply for quotation of securities. It details the issuance and quotation of securities resulting from the exercise of options or conversion of convertible securities. The document includes specifics such as the number of securities, issue date, and whether the securities are new or existing class. It is not a financial report, earnings release, or management discussion, but rather a formal announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not merely an announcement of a report but a substantive filing about securities quotation.
2024-09-03 English
Notification of cessation of securities - XRF 4 pages 14.8KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse of performance rights securities for XRF Scientific Limited. It provides specific information about securities that have ceased, reasons for cessation, and updated issued capital figures. This type of announcement is related to changes in the company's capital structure, specifically the cessation (lapse) of certain securities. It is not a full financial report, audit, or management discussion, nor is it a voting result or AGM material. The document fits the category of Share Issue/Capital Change announcements, which cover new share issues, stock splits, or other capital changes including cessation of securities.
2024-09-03 English
2024 Appendix 4G & Corporate Governance Statement 22 pages 360.1KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance disclosure document related to the corporate governance statement for the financial year ended 30 June 2024. The document includes detailed tables indicating compliance with corporate governance recommendations and points to where the corporate governance statement can be found (either in the annual report or on the website). It explicitly states that Appendix 4G is not a substitute for the corporate governance statement but serves as a key to disclosures and a verification tool. The document is a regulatory filing required to be lodged with ASX alongside the annual report but is not the annual report itself. It does not contain financial statements or management discussion but focuses on governance disclosures and compliance with ASX corporate governance principles. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-27 English
Preliminary Final Report 4 pages 134.9KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4E - Preliminary final report XRF Scientific Limited For the period ended 30 June 2024' and references the 2024 Annual Report multiple times, indicating it is a preliminary final report for a full fiscal year ending 30 June 2024. It contains key financial metrics such as revenue, profit, dividends, net tangible assets, and other financial data for the 12-month period. The document also states it is prepared under Australian Accounting Standards and mentions the accounts have been audited, with the audit report included in the Annual Report. The document is over 10,000 characters, indicating it is substantive and not merely an announcement or certification. The Appendix 4E is a regulatory form used in Australia to announce preliminary final results, which is a type of comprehensive annual financial report but not the full Annual Report itself. Given the detailed financial data and the nature of the document as a preliminary final report, the best classification is Interim / Quarterly Report (IR), as Appendix 4E is typically considered an interim disclosure of annual results prior to the full Annual Report. It is not the full Annual Report (10-K) itself, nor just an announcement (RPA). FY 2024
2024-08-19 English
Annual Report to shareholders 65 pages 1.6MB
Annual Report Classification · 100% confidence The document is titled 'ANNUAL FINANCIAL REPORT' and includes comprehensive sections typical of an annual report such as Chairman's Letter, Directors' Report, Auditor's Independence Declaration, consolidated financial statements (profit or loss, financial position, changes in equity, cash flows), notes to financial statements, directors' declaration, and auditor's report. It covers the full fiscal year ended 30 June 2024 and provides detailed financial results, operational review, dividend information, and governance disclosures. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or summary. Therefore, this document is the full Annual Report for the fiscal year 2024. FY 2024
2024-08-19 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.